Characteristics of the Patients Studied
. | No. of Patients . | Frequency (%) . |
---|---|---|
Sex | ||
Female | 28 | 90 |
Male | 3 | 10 |
Age | ||
≤35 yr | 22 | 71 |
>35 yr | 9 | 29 |
Onset | ||
≤1 yr | 13 | 42 |
>1 yr | 18 | 58 |
Severity grade | ||
I | 2 | 6 |
IIA | 4 | 13 |
IIB | 25 | 81 |
Thymus histology | ||
Normal or involuted | 12 | 39 |
Hyperplasia + | 6 | 19 |
Hyperplasia ++ | 13 | 42 |
Steroid treatment | ||
No | 27 | 88 |
Yes | 4 | 12 |
Anti-AChR Ab titers (nmol/L) | ||
<1 | 10 | 32 |
1-10 | 11 | 36 |
>10 | 10 | 32 |
. | No. of Patients . | Frequency (%) . |
---|---|---|
Sex | ||
Female | 28 | 90 |
Male | 3 | 10 |
Age | ||
≤35 yr | 22 | 71 |
>35 yr | 9 | 29 |
Onset | ||
≤1 yr | 13 | 42 |
>1 yr | 18 | 58 |
Severity grade | ||
I | 2 | 6 |
IIA | 4 | 13 |
IIB | 25 | 81 |
Thymus histology | ||
Normal or involuted | 12 | 39 |
Hyperplasia + | 6 | 19 |
Hyperplasia ++ | 13 | 42 |
Steroid treatment | ||
No | 27 | 88 |
Yes | 4 | 12 |
Anti-AChR Ab titers (nmol/L) | ||
<1 | 10 | 32 |
1-10 | 11 | 36 |
>10 | 10 | 32 |